Davidson Kempner Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Davidson Kempner Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-155,631	Closed	-$34.4M	–	240
2025 Q4	$34.4M	Buy	+155,631	New	+$25.2M	0.4%	60

Davidson Kempner Capital Management's CDTX Position: Q1 2026 in Review

Davidson Kempner Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 155,631 shares — an estimated $34.4M sold.

Davidson Kempner Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $34.4M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Davidson Kempner Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Davidson Kempner Capital Management sold 155,631 Cidara Therapeutics shares in Q1 2026, an estimated $34.4M.
Davidson Kempner Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Davidson Kempner Capital Management's Cidara Therapeutics position peaked at $34.4M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Davidson Kempner Capital Management's 13F filing for Q1 2026, filed 15 May 2026.